Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122638) titled 'Research and Clinical Application of an Early Diagnosis System for Alzheimer's Disease Based on Retina-Brain Combined Biomarkers' on April 16.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Affiliated Kangning Hospital of Ningbo University
Condition:
Alzheimer's Disease
Intervention:
Case Group (AD Patients):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-25
Target Sample Size: Case Group (AD Patients):100;Control Group (Non-AD Population):100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...